Neuro-Oncology Reviews
Volume
26 Number 17
20 August 2024
Home > Publications > Neuro-Oncology Reviews > Volume 26, Year 2024 > Number 17, 20 August
Lu J, Huo W, Ma Y, Wang X, Yu J.
Suppressive
immune microenvironment and CART therapy for glioblastoma: Future
prospects and challenges.
Cancer
Lett. 2024 Aug 12;600:217185. doi:
10.1016/j.canlet.2024.217185. PMID:
39142498. Review. ˍ
Farzad Maroufi S, Sadegh Fallahi M, Parmis Maroufi S, Sheehan JP.
Focused ultrasound blood-brain barrier
disruption in high-grade gliomas: Scoping review of clinical
studies.
J
Clin Neurosci. 2024 Aug 14;128:110786. doi:
10.1016/j.jocn.2024.110786? PMID:
39146579. Review˰ ˍ
Caverzan MD, Ibarra LE.
Advancing
glioblastoma treatment through iron metabolism: A focus on TfR1
and Ferroptosis innovations.
Int
J Biol Macromol. 2024 Aug 15;278(Pt 2):134777. doi:
10.1016/j.ijbiomac.2024.134777. PMID:
39153669. Review˰ ˍ
Lucchini S, Constantinou M, Marino S.
Unravelling
the mosaic: Epigenetic diversity in glioblastoma.
Mol
Oncol. 2024 Aug 15. doi:
10.1002/1878-0261.13706. PMID:
39148319. Review. ˍ
Yaman Bajin I, Bouffet E.
Advances in
the Treatment of Pediatric Low-Grade Gliomas.
Curr
Neurol Neurosci Rep. 2024 Aug 15. doi:
10.1007/s11910-024-01369-4. PMID:
39143379. Review˰ ˍ
Zarychta J, Kowalczyk A, Marszołek A, Zawitkowska J, Lejman
M.
Strategies to overcome tumor
microenvironment immunosuppressive effect on the functioning of
CAR-T cells in high-grade glioma.
Ther
Adv Med Oncol. 2024 Aug 15;16:17588359241266140. doi:
10.1177/17588359241266140. PMID:
39156126. Review. ˍ
Cini NT, Pennisi M, Genc S, Spandidos DA, Falzone L, Mitsias PD,
Tsatsakis A, Taghizadehghalehjoughi A.
Glioma
lateralization: Focus on the anatomical
localization and the distribution of
molecular alterations (Review).
Oncol
Rep. 2024 Aug 16;52(4):139. doi:
10.3892/or.2024.8798. PMID:
39155859. Review. ˍ
Garcia-Moure M, Laspidea V, Gupta S, Gillard AG, Khatua S,
Parthasarathy A, He J, Lang FF, Fueyo J, Alonso MM, Gomez-Manzano
C.
The Emerging Field of
Viroimmunotherapy for Pediatric Brain Tumors.
Neuro
Oncol. 2024 Aug 16:noae160. doi:
10.1093/neuonc/noae160. PMID:
39148489. Review˰ ˍ
Habibi MA, Shad N, Mirjnani MS, Fasihi S, Sadeghi S, Karami S,
Ahmadvand MH, Delbari P, Zare AH, Zare AH, Alavi SAN.
Is
add-on Bevacizumab therapy to
Temozolomide and radiotherapy
associated with clinical utility for newly
diagnosed Glioblastoma? A systematic
review and meta-analysis.
Neurosurg
Rev. 2024 Aug 20;47(1):445. doi:
10.1007/s10143-024-02667-8. PMID:
39162874. Review; Meta-analysis˰
ˍ
*Rangwala BS, Shakil A, Mustafa MS, Rangwala HS, Fatima H, Siddiq
MA.
Losartan and Immune Checkpoint
Inhibitors in Glioblastoma: An Appropriate Substitute for
Steroids.
Ann
Neurosci. 2023 Nov 3;31(3):152-154. doi:
10.1177/09727531231191880. PMID:
39156623. Perspective. ˍ
Viani GA, Gouveia AG, Arcidiacono F, Marta GN, Hamamura AC,
Anselmo P, Barbosa FS, Moraes FY.
Efficacy
and safety of hypofractionated radiotherapy versus conventional
fractionated radiotherapy in diffuse intrinsic pontine glioma: A
systematic review and meta-analysis.
Rep
Pract Oncol Radiother. 2024 Jun 3;29(3):309-317. doi:
10.5603/rpor.100779. PMID:
39144263. Review; Meta-analysis. ˍ
Ali TE, Rodoshi ZN, Salcedo YE, Patel VK, Khan I.
Optimizing
Glioma Resection Outcomes: A Systematic Review of Intraoperative
Magnetic Resonance Imaging Guidance in Neurosurgery.
Cureus.
2024 Jul 16;16(7):e64697. doi:
10.7759/cureus.64697. PMID:
39156414. Review. ˍ
Usmani S, Riyami KA, Numani SP, Hashmi SF, Jain A, Sukaiti RA,
Ahmed N, Shamim MS.
Molecular imaging
with 68Ga-PSMA PET/CT in high grade glioma: A biomarker for tumour
neo-angiogenesis.
J
Pak Med Assoc. 2024 Jul 25;74(8):1552-1554. doi:
10.47391/JPMA.24-64. PMID:
39160736. Review. ˍ
Mlika M, Mokni M, Mezni F, Rammeh S.
Daily
management of gliomas, glioneuronal, and neuronal tumors in the
era of the 2021 WHO classification of nervous tumors.
Front
Neurol. 2024 Jul 29;15:1407572.
doi:
10.3389/fneur.2024.1407572. PMID:
39135755. Perspective. ˍ
Li J, Zhang Y, Liang C, Yan X, Hui X, Liu Q.
Advancing
precision medicine in gliomas through single-cell sequencing:
unveiling the complex tumor microenvironment.
Front
Cell Dev Biol. 2024 Aug 2;12:1396836. doi:
10.3389/fcell.2024.1396836. PMID:
39156969. Review. ˍ
Meng D, Dong Y, Shang Q, Sun Z.
Anti-tumor
effect and hepatotoxicity mechanisms of psoralen.
Front
Pharmacol. 2024 Aug 5;15:1442700. doi:
10.3389/fphar.2024.1442700. PMID:
39161897. Review. ˍ